Skip to main content

Ultragenyx Pharmaceutical Inc. - Common Stock (NQ: RARE )

44.22 +0.75 (+1.73%)
Streaming Delayed Price Updated: 4:00 PM EST, Dec 20, 2024 Add to My Watchlist

Other Filings

Form 8-K
Source: SEC/Edgar
October 19, 2004
Form 8-K
Source: SEC/Edgar
October 03, 2004
Form 8-K
Source: SEC/Edgar
July 20, 2004
Form S-8
Source: SEC/Edgar
June 08, 2004
Form 8-K
Source: SEC/Edgar
April 20, 2004
Form DEF 14A
Source: SEC/Edgar
April 11, 2004
Form SC 13G
Source: SEC/Edgar
February 11, 2004
Form 8-K
Source: SEC/Edgar
February 10, 2004
Form SC 13G/A
Source: SEC/Edgar
February 05, 2004
Form 8-K
Source: SEC/Edgar
October 21, 2003
Form 8-K
Source: SEC/Edgar
July 22, 2003
Form 8-K
Source: SEC/Edgar
July 07, 2003
Form DEF 14A
Source: SEC/Edgar
April 10, 2003
Form 10-K/A
Source: SEC/Edgar
April 02, 2003
Form SC 13G/A
Source: SEC/Edgar
February 11, 2003
Form SC 13G/A
Source: SEC/Edgar
February 10, 2003
Form SC 13G/A
Source: SEC/Edgar
December 09, 2002
Form S-8
Source: SEC/Edgar
August 05, 2002
Form DEF 14A
Source: SEC/Edgar
April 09, 2002
Form SC 13G/A
Source: SEC/Edgar
February 14, 2002
Form SC 13G
Source: SEC/Edgar
February 11, 2002
Form SC 13G
Source: SEC/Edgar
February 07, 2002
Form SC 13G/A
Source: SEC/Edgar
February 07, 2002
Form SC 13G/A
Source: SEC/Edgar
February 06, 2002
Form 8-K
Source: SEC/Edgar
September 17, 2001
Form DEF 14A
Source: SEC/Edgar
April 10, 2001
Form PRE 14A
Source: SEC/Edgar
March 29, 2001
Form 8-K
Source: SEC/Edgar
February 22, 2001
Form SC 13G/A
Source: SEC/Edgar
February 11, 2001
Form 8-K
Source: SEC/Edgar
February 08, 2001
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.